For a regular user of cannabis, the chemical structure of the product that he is consuming is perhaps not much of a concern. But for lawmakers, it is very much a concern. It is centered around the two main chemical variants of the product- cannabidiol (CBD) and tetrahydrocannabinol (THC). However, it is important to point out that CBD is the most popular variant that is used for recreational and medicinal purposes. On the other hand, the THC variant of the product is largely illegal in most parts of the world. More importantly, the effect that the two variants of cannabis have on an individual is perhaps the biggest difference between the CBD and THC.
As everyone knows, there is very little difference in the chemical composition of CBD and THC. The main difference lies in the effects they have on an individual. CBD has a much more calming effect and is known for having this relaxing effect. In comparison, THC is known to have the sort of effects that gives cannabis a bad name. THC is known to make people high and have psychological effects like hallucinations and loss of memory among others.
As a result, it is not a surprise that cannabis with a high degree of THC is banned in the state of Wisconsin. This is the key difference between the two strains. At the same time, it is important to keep in mind that cannabis contains a bit of both.
When it comes to buying cannabis, a consumer should look at the CBD and THC content in the product. Most cannabis manufacturers list the amount of CBD and THC that is contained in a product. This allows the consumer to make a choice with ease. In addition to that, most of the cannabis products that are sold over the counter have a higher percentage of CBD and only minuscule amounts of THC.
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers